- Raises $50 M to acquire over 1 M HYPE tokens
- First U.S. public company to hold HYPE treasury
- Plans staking via Anchorage Digital; rebrands as Hyperion DeFi
Eyenovia, originally a Nasdaq-listed biotech firm focused on ophthalmic delivery systems, is making a bold transition into the crypto space. The company has raised $50 million through a private placement, which it will use to purchase over 1 million HYPE tokens—becoming the first U.S. public company to hold HYPE in its treasury.
This move signals a strategic shift to diversify assets, enhance yield potential, and participate in decentralized finance (DeFi). It also reflects a broader trend where traditional firms explore blockchain integration for financial resilience and growth.
Strategic Rationale: Merging Innovation and Finance
By investing in HYPE tokens, Eyenovia aims to hedge against traditional market volatility and unlock yield through crypto staking. This approach offers long-term potential for both capital appreciation and revenue generation, marking a new era in corporate treasury management.
Execution Plan & Leadership
The funding involves the issuance of convertible preferred shares and warrants, allowing for future capital expansion up to $150 million. Eyenovia will stake its HYPE tokens using Anchorage Digital, a trusted platform for institutional crypto custody.
To steer this transformation, Eyenovia has appointed Hyunsu Jung as Chief Investment Officer. Jung brings deep expertise in crypto and DeFi, strengthening the leadership team for this new strategic path. As part of the shift, the company will rebrand as Hyperion DeFi, with a new ticker symbol “HYPD” starting June 20, 2025.
Read also:
- Near AI’s IronClaw Aims to Protect Private Keys
- What is Zero Knowledge Proof? The Secret Weapon Solving AI’s Privacy Breakdown in 2026
- Stablecoins Lead Fastest-Growing Tokenized Asset Deployments
- BlockDAG Switches On Mainnet As Traders Rush to Secure $0.00025 Entry! ADA and LTC Stabilize
- Strategy Shares Fall Harder Than Bitcoin
